The University of Prince Edward Island celebrated the launch of a new contract research company based partly on UPEI technology. Bio-valuation Outsourcing Solution (BioVOS) provides services to the pharmaceutical industry to test new drugs and treatments for neuro-inflammatory, metabolic, and cardiovascular disorders, including stroke and heart disease.

“Pharmaceutical companies face real challenges when bringing a new drug to market,” says Dr. Tarek Saleh, Professor of Biomedical Sciences at UPEI’s Atlantic Veterinary College and CEO of BioVOS. “Drug development takes up to 15 years with a success rate of just one in five thousand at an average cost of more than a billion dollars. Contract research organizations, such as BioVOS, can help streamline that process and make it more affordable.”

For more information, please visit this link.